The aim of this study was to the evaluation of frequency and distribution of Serratia marcescens in the hospital departments and determination of antimicrobial resistance of the isolated strains. Methods: The study included 81 Serratia marcescens strains isolated from 61 patients hospitalized in the in the different hospital wards of Al-Noor Specialist Hospital within the period from 1/11/2012 to 1/11/2013. The strains were isolated from wound swabs, blood cultures, sputum, urine culture, fluid, catheter and throat swab, wound swabs, blood cultures and cerebrospinal fluid. Results: The isolates were identified by conventional method and the results and susceptibility testing were confirmed by VITEC-2 Compact. Most frequently Serratia marcescens has been implicated in ICU [21%] followed by male medical [18.5%] and emergency department [12.3%]. The resistance of Serratia strains was high, excepting imipenem (15%), Meropenem (27) and the resistance was higher with ampicillin (97.5%), Cefoxitin (90%) and Tetracycline (86%). Conclusion: Continuous monitoring of nosocomial infections is indispensable. Phenotypic characterization of the isolates is useful for studying the relationship of microbial pathogens.
References
[1]
Musham, C.K., Jarathi, A. and Agarwal, A. (2012) Acute Epiglottitis Due to Serratia marcescens in an Immune Competent Adult. The American Journal of the Medical Sciences, 344, 153-154.
[2]
Polilli, E., Parruti, G., Fazii, P., et al. (2011) Rapidly Controlled Outbreak of Serratia marcescens Infection/Colonization in a Neonatal Intensive Care Unit, Pescara General Hospital, Pescara, April 2011. Euro Surveill, 16.
[3]
Hejazi, A. and Falkiner, F.R. (1997) Serratia marcescens. Journal of Medical Microbiology, 46, 903-912. http://dx.doi.org/10.1099/00222615-46-11-903
[4]
Wheat, R.P., Zuckerman, A. and Rantz, L.A. (1951) Infection Due to Chromobacteria: Report of Eleven Cases. JAMA Internal Medicine, 88, 461-466. http://dx.doi.org/10.1001/archinte.1951.03810100045004
Sautter, R.L., Mattman, K.H. and Legaspi, R.C. (1984) Serratia marcescens Meningitis Associated with a Contaminated Benzalkonium Chloride Solution. Infection Control, 5, 223-225.
[7]
Buffet-Bataillon, S., Rabier, V., Betremieux, P., Beuchee, A., Bauer, M., Pladys, P., et al. (2009) Outbreak of Serratia marcescens in a Neonatal Intensive Care Unit: Contaminated Unmediated Liquid Soap and Risk Factors. Journal of Hospital Infection, 72, 17-22. http://dx.doi.org/10.1016/j.jhin.2009.01.010
[8]
De Vries, J.J., Baas, W.H., van der Ploeg, K., Heesink, A., Degener, J.E. and Arends, J.P. (2006) Outbreak of Serratia marcescens Colonization and Infection Traced to a Healthcare Worker with Long-Term Carriage on the Hands. Infection Control and Hospital Epidemiology, 27, 1153-1158.
[9]
Bennett, P.M. and Chopral. I. (1993) Molecular Basis of Beta-Lactamase Induction in Bacteria. Antimicrobial Agents and Chemotherapy, 37, 153-158. http://dx.doi.org/10.1128/AAC.37.2.153
[10]
Wul, T., Tsou, M.F., Wu, H.J., Chen, H.E., Chuang, Y.C. and Yu, W.L. (2004) Survey of CTX-3 Extended-Spectrum Beta-Lactamase (ESBL) among Cefotaxime-Resistant Serratia marcescens at a Medical Center in Middle Taiwan. Diagnostic Microbiology and Infectious Disease, 49, 125-129. http://dx.doi.org/10.1016/j.diagmicrobio.2004.02.004
[11]
Henjyoji, E.Y., Whitson, T.C., Oashi, D.K. and Allen, B.D. (1971) Bacteremia Due to Serratia marcescens. The Journal of Trauma, 11, 417-421. http://dx.doi.org/10.1097/00005373-197105000-00006
[12]
Yu, W.L., Lin, C.W. and Wang, D.Y. (1998) Serratia marcescens Bacteremia: Clinical Features and Antimicrobial Susceptible of the Isolates. Journal of Microbiology, Immunology, and Infection, 31, 171-179.
[13]
Jorgansen, H.J. (2011) Antibacterial Agents and Susceptibility Test Methods. In: Versolovic, J., Caroll, K.C., Funke, G., Jorgansen, H.J., Landry, M.L and Warnock, D.W., Eds., Manual of Clinical Microbiology, 10th Edition, Vol. 1, American Society for Microbiology, Texas.
[14]
Clinical and Laboratory Standards Institute (2005) Performance Standards for Antimicrobial Susceptibility Testing. CLSI, Wayne, CLSI Document M100-S15.
[15]
Hejazi, A. and Falkiner, F.R. (1997) Serratia marcescens. Journal of Medical Microbiology, 46, 903-912. http://dx.doi.org/10.1099/00222615-46-11-903
[16]
Sleigh, J.D. (1983) Antibiotic Resistance in Serratia marcescens. British Medical Journal, 287, 1651-1653. http://dx.doi.org/10.1136/bmj.287.6406.1651
[17]
Knowles, S., Herra, C., Devitt, E., O’Brien, A., Mulvihill, E., McCann, S.R., et al. (2000) An Outbreak of Multi-Ply Resistant Serratia marcescens: The Importance of Persistent Carriage. Bone Marrow Transplantation, 25, 873-877. http://dx.doi.org/10.1038/sj.bmt.1702218
[18]
Bosi, C., Davin-Regli, A., Charrel, R., Rocca, B., Monnet, D. and Bollet, C. (1996) Serratia marcescens Nosocomial Outbreak Due to Contamination of Hexetidine Solution. Journal of Hospital Infection, 33, 217-224. http://dx.doi.org/10.1016/S0195-6701(96)90005-5
[19]
Vandenbroucke-Grauls, C.M., Baars, A.C., Visser, M.R., Hulstaert, P.F. and Verhoef, J. (1993) An Outbreak of Serratia marcescens Traced to a Contaminated Bronchoscope. Journal of Hospital Infection, 23, 263-270.
[20]
Miranda, G., Kelly, C., Solorzano, F., Leanos, B., Coria, R. and Patterson, J.E. (1996) Use of Pulsed-Field Gel Electrophoresis Typing to Study an Outbreak of Infection Due to Serratia marcescens in a Neonatal Intensive Care Unit. Journal of Clinical Microbiology, 34, 3138-3141.
[21]
Choi, S.H., Lee, J.E., et al. (2007) Prevalence, Microbiology, and Clinical Characteristics of Extended-Spectrum Beta-Lactamase-Producing Enterobacter spp., Serratia marcescens, Citrobacter freundii and Morganella morganii in Korea. European Journal of Clinical Microbiology & Infectious Diseases, 26, 557-561. http://dx.doi.org/10.1007/s10096-007-0308-2
[22]
Dubouix, A., Roques, C., Segonds, C., et al. (2005) Epidemiological Investigation of a Serratia liquefaciens Outbreak in a Neurosurgery Department. Journal of Hospital Infections, 60, 8-13. http://dx.doi.org/10.1016/j.jhin.2004.09.029
[23]
Fleisch, F., Zimmermann-Baer, U., et al. (2002) Three Consecutive Outbreaks of Serratia marcescens a Neonatal Intensive Care Unit. Clinical Infections Diseases, 34, 767-773.
[24]
Iosifidis, E., Farmaki, E., et al. (2012) Outbreak of Bloodstream Infections Because of Serratia marcescens in a Pediatric Department. American Journal of Infection Control, 40, 11-15. http://dx.doi.org/10.1016/j.ajic.2011.03.020
[25]
Rajput, A., Shah, U., et al. (2009) Serratia—An Emerging Pathogen in Hospital Environment. Gujarat Medical Journal, 64, 70-71.
[26]
Sethuraman, S., Arunachalam, A., et al. (2011) Antimicrobial Sensitivity Profile of Serratia marcescens Strains Isolated in Government General Hospital, Nagapattinam, Tamilnadu, India. International Journal of Preclinical and Pharmaceutical Research, 2, 7-11.
[27]
Kumar, A. and Worobec, E. (2002) Fluoroquinolone Resistance of Serratia marcescens: Involvement of a Proton Gradient-Dependent Efflux Pump. Journal of Antimicrobial Chemotherapy, 50, 593-596.
[28]
Emily, R.M. (2011) Sydnor and Trish M. Hospital Epidemiology and Infection Control in Acute-Care Settings. Clinical Microbiology Reviews, 24, 141-173. http://dx.doi.org/10.1128/CMR.00027-10
